
Summarize 2 studies on Iron-Deficiency
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
-
Narrated by:
-
By:
About this listen
Have ever tried to use AI on publications. Not just summarizing, but explore complicated topic in an easy to hear podcast?
This is for you, talking about:
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency AnemiaJAMA. 2020;323(5):432-443. doi:10.1001/jama.2019.22450
Myles Wolf, MD, MMSc; Janet Rubin, MD; Maureen Achebe, MD; Michael J. Econs, MD; Munro Peacock, MD; Erik A. Imel, MD; Lars L. Thomsen, MD; Thomas O. Carpenter, MD; Thomas Weber, MD; Vincent Brandenburg, MD; Heinz Zoller, MD AND
A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United KingdomJournal of Medical Economics, DOI: 10.1080/13696998.2020.1745535
No reviews yet